Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genetic Engineering & Biotechnology News (GEN) is a premier and highly respected publication that has been a leading source of information in the biotechnology and life sciences field since 1981. GEN provides comprehensive coverage of the latest breakthroughs, industry trends, research, and technological advancements in areas such as drug discovery, bioprocessing, omics, gene editing (including CRISPR), cancer research, and diagnostics. It serves a global audience of scientists, researchers, executives, investors, and policymakers involved in the biotech and pharmaceutical industries through its print magazine, website, newsletters, webinars, and podcasts.
Serves as the primary editorial, publishing, and administrative hub for Genetic Engineering & Biotechnology News and other peer-reviewed journals and trade publications by Mary Ann Liebert, Inc.
Modern office facilities equipped to support a leading STM (Scientific, Technical, and Medical) publishing house, including editorial suites and production departments.
A dynamic, deadline-driven, and intellectually stimulating environment focused on scientific accuracy, editorial excellence, and innovation in publishing. It fosters collaboration among editors, writers, production staff, and sales teams dedicated to serving the biotechnology community.
The central point for content creation, editorial decision-making, strategic planning, and distribution for Genetic Engineering & Biotechnology News, a key information resource for the global biotech industry.
Genetic Engineering & Biotechnology News (GEN) maintains a significant global presence through its wide readership and international contributor network. Its digital platform ensures worldwide accessibility to its news, articles, webinars, and other resources. GEN covers international biotechnology conferences, research breakthroughs, and market trends, reflecting its commitment to serving a global audience of professionals in the life sciences sector. While its primary publishing operations are based in the US, its editorial scope, sourcing, and impact are inherently global.
140 Huguenot Street, 3rd Floor
New Rochelle
NY
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genetic Engineering & Biotechnology News' leadership includes:
Genetic Engineering & Biotechnology News has been backed by several prominent investors over the years, including:
Specific executive hires or exits directly within the Genetic Engineering & Biotechnology News (GEN) core team are not frequently publicized as major corporate news. Key leadership tends to be stable. Changes, if any, are typically internal or part of the broader Mary Ann Liebert, Inc. publishing group's staffing adjustments, which may not always be publicly detailed unless they involve very senior roles.
Discover the tools Genetic Engineering & Biotechnology News uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email addresses for personnel at Genetic Engineering & Biotechnology News (GEN) typically use the domain of its publisher, Mary Ann Liebert, Inc. (@liebertpub.com). Common formats include first initial followed by last name.
[first_initial][last]@liebertpub.com
Format
jdoe@liebertpub.com
Example
75%
Success rate
GEN - Genetic Engineering & Biotechnology News • October 25, 2023
Jonathan Grinstein, PhD, science editor at GEN, won a 2023 Folio: Eddie Award in the B2B Science and Technology category for his article “CAR T-Cell Therapy Searches for Paths to Allogeneic Future.” The Eddie & Ozzie Awards are a prestigious recognition program in the publishing community....more
GEN - Genetic Engineering & Biotechnology News • February 1, 2024
GEN Edge, the premium subscription service from Genetic Engineering & Biotechnology News, announced its attendance and coverage plans for the Biotech Showcase 2024, highlighting its role in providing in-depth analysis and insights for the biotech investment community....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genetic Engineering & Biotechnology News, are just a search away.